-
November 21, 2012
Medical devices major, St. Jude Medical, Inc.'s (STJ) recently won European CE Mark approval for its 23 mm Portico ...
-
November 20, 2012
Medtronic Inc. (MDT) reported second quarter fiscal 2013 earnings per share (EPS) of 63 cents, down 23% year over ...
-
November 20, 2012
Medtronic (NYSE:MDT) announced its results for the most recent quarter on November 20, 2012. Medtronic provides ...
-
November 19, 2012
Alnylam Pharmaceuticals, Inc. (ALNY) and Tekmira Pharmaceuticals Corporation recently signed a new licensing ...
-
November 15, 2012
Following the third quarter earnings release, we are maintaining our long-term 'Neutral' recommendation on DexCom ...
-
November 15, 2012
Medtronic (NYSE:MDT) is scheduled to announce its second quarter earnings on Tuesday, November 20, 2012. Investors ...
-
November 12, 2012
Medical devices major St. Jude Medical, Inc.'s (STJ) recently revealed positive data from the EnligHTN trial, ...
-
November 12, 2012
Viewing the huge potential of the renal denervation market, Boston Scientific (BSX) plans to acquire Vessix ...
-
November 05, 2012
DexCom (DXCM), a player in the glucose monitoring market, reported third quarter 2012 loss per share of 25 cents, ...
-
November 02, 2012
United Therapeutics Corp. (UTHR) reported third-quarter earnings of $1.46 per share, well above the year-ago ...
-
November 01, 2012
Boston Scientific's (BSX) coronary stent portfolio was boosted with the CE Mark approval of its Synergy ...
-
October 31, 2012
Leading medical devices player, Medtronic (MDT) presented positive data from the pivotal trial of its Engager ...
-
October 29, 2012
Integra LifeSciences Holdings Corporation (IART) reported earnings per share ('EPS') of 46 cents in the third ...
-
October 26, 2012
Greatbatch, Inc.'s (GB) third-quarter 2012 adjusted earnings per share of 46 cents beat the Zacks Consensus Estimate ...
-
October 22, 2012
Edwards Lifesciences Corporation (EW) reported earnings of 58 cents per share in the third quarter of 2012 (within ...
-
October 18, 2012
Boston Scientific (BSX) reported a net loss of $725 million or 52 cents per share in the third quarter of 2012, a ...
-
October 17, 2012
Medical devices major, St. Jude Medical, Inc.'s (STJ) third quarter 2012 adjusted earnings of 83 cents per share ...
-
October 16, 2012
Boston Scientific (BSX) is scheduled to release its first quarter fiscal 2011 earnings on April 20, 2011 after the ...
-
October 15, 2012
Medical device major St. Jude Medical (STJ) is slated to announce its second quarter results before the opening bell ...
-
October 11, 2012
Boston Scientific Corporation (BSX) is making good progress in the REPRISE II clinical trial. The company enrolled ...
